Oliveto Joseph
Related Filers (2)
Ownership (17)
4
Friday, 2/17/2023
Milestone Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/23/2022
Milestone Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/26/2021
Milestone Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/8/2020
Milestone Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/24/2020
Milestone Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/8/2019
Milestone Pharmaceuticals Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/25/2014
Chelsea Therapeutics International, Ltd.: Statement of changes in beneficial ownership of securities
4
Friday, 1/24/2014
Chelsea Therapeutics International, Ltd.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/9/2013
Chelsea Therapeutics International, Ltd.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/11/2012
Chelsea Therapeutics International, Ltd.: Statement of changes in beneficial ownership of securities
4
Friday, 1/27/2012
Chelsea Therapeutics International, Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2011
Chelsea Therapeutics International, Ltd.: Statement of changes in beneficial ownership of securities
4
Monday, 8/16/2010
Chelsea Therapeutics International, Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/21/2010
Chelsea Therapeutics International, Ltd.: Statement of changes in beneficial ownership of securities
4
Monday, 1/26/2009
Chelsea Therapeutics International, Ltd.: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/17/2008
Chelsea Therapeutics International, Ltd.: Initial statement of beneficial ownership of securities
4
Tuesday, 6/17/2008
Chelsea Therapeutics International, Ltd.: Statement of changes in beneficial ownership of securities